Could higher quality data encourage generic drugs to be used for new indications?


According to new research by the Repurposing Drugs in Oncology (ReDO) project, higher quality data could help convince pharma firms to pay for trials to see if generic drugs could be used for new indications. The ReDO project’s goal is to identify generic drugs that could be used as low cost treatments for different diseases.

Read the source article at Pharmaceutical Industry – News from In

About the Author

Related Posts

Leave a Reply